Publication

Rho-kinase inhibitor coupled with peptide-modified albumin carrier reduces fibrogenesis and portal pressure in cirrhotic rats without systemic effects

Magdaleno, F., Klein, S., Frohn, F., Reker-Smit, C., Uschner, F. E., Schierwagen, R., Poelstra, K., Beljaars, L. & Trebicka, J., Oct-2017, In : Hepatology. 66, 1 (Suppl.), p. 142A-142A 1 p.

Research output: Contribution to journalMeeting AbstractAcademic

APA

Magdaleno, F., Klein, S., Frohn, F., Reker-Smit, C., Uschner, F. E., Schierwagen, R., ... Trebicka, J. (2017). Rho-kinase inhibitor coupled with peptide-modified albumin carrier reduces fibrogenesis and portal pressure in cirrhotic rats without systemic effects. Hepatology, 66(1 (Suppl.)), 142A-142A.

Author

Magdaleno, Fernando ; Klein, Sabine ; Frohn, Franziska ; Reker-Smit, Catharina ; Uschner, Frank E. ; Schierwagen, Robert ; Poelstra, Klaas ; Beljaars, Leonie ; Trebicka, Jonel. / Rho-kinase inhibitor coupled with peptide-modified albumin carrier reduces fibrogenesis and portal pressure in cirrhotic rats without systemic effects. In: Hepatology. 2017 ; Vol. 66, No. 1 (Suppl.). pp. 142A-142A.

Harvard

Magdaleno, F, Klein, S, Frohn, F, Reker-Smit, C, Uschner, FE, Schierwagen, R, Poelstra, K, Beljaars, L & Trebicka, J 2017, 'Rho-kinase inhibitor coupled with peptide-modified albumin carrier reduces fibrogenesis and portal pressure in cirrhotic rats without systemic effects', Hepatology, vol. 66, no. 1 (Suppl.), pp. 142A-142A.

Standard

Rho-kinase inhibitor coupled with peptide-modified albumin carrier reduces fibrogenesis and portal pressure in cirrhotic rats without systemic effects. / Magdaleno, Fernando; Klein, Sabine; Frohn, Franziska; Reker-Smit, Catharina; Uschner, Frank E.; Schierwagen, Robert; Poelstra, Klaas; Beljaars, Leonie; Trebicka, Jonel.

In: Hepatology, Vol. 66, No. 1 (Suppl.), 10.2017, p. 142A-142A.

Research output: Contribution to journalMeeting AbstractAcademic

Vancouver

Magdaleno F, Klein S, Frohn F, Reker-Smit C, Uschner FE, Schierwagen R et al. Rho-kinase inhibitor coupled with peptide-modified albumin carrier reduces fibrogenesis and portal pressure in cirrhotic rats without systemic effects. Hepatology. 2017 Oct;66(1 (Suppl.)):142A-142A.


BibTeX

@article{1d2065e8938c41be9dad12831e4dfc41,
title = "Rho-kinase inhibitor coupled with peptide-modified albumin carrier reduces fibrogenesis and portal pressure in cirrhotic rats without systemic effects",
author = "Fernando Magdaleno and Sabine Klein and Franziska Frohn and Catharina Reker-Smit and Uschner, {Frank E.} and Robert Schierwagen and Klaas Poelstra and Leonie Beljaars and Jonel Trebicka",
year = "2017",
month = "10",
language = "English",
volume = "66",
pages = "142A--142A",
journal = "Hepatology",
issn = "0270-9139",
publisher = "Wiley",
number = "1 (Suppl.)",

}

RIS

TY - JOUR

T1 - Rho-kinase inhibitor coupled with peptide-modified albumin carrier reduces fibrogenesis and portal pressure in cirrhotic rats without systemic effects

AU - Magdaleno, Fernando

AU - Klein, Sabine

AU - Frohn, Franziska

AU - Reker-Smit, Catharina

AU - Uschner, Frank E.

AU - Schierwagen, Robert

AU - Poelstra, Klaas

AU - Beljaars, Leonie

AU - Trebicka, Jonel

PY - 2017/10

Y1 - 2017/10

M3 - Meeting Abstract

VL - 66

SP - 142A-142A

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 1 (Suppl.)

ER -

ID: 49533357